Hansberger Global Investors’s Novo Nordisk NVO Stock Holding History

Hansberger Global Investors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.33M	Hold	57,500	–	–	0.37%	19
2014 Q1	$1.31M	Hold	57,500	–	–	0.31%	33
2013 Q4	$1.06M	Sell	57,500 -11,770	-17%	-$205K	0.24%	37
2013 Q3	$1.17M	Sell	69,270 -9,340	-12%	-$157K	0.22%	40
2013 Q2	$1.22M	Buy	+78,610	New	+$1.31M	0.27%	39

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.42% 1-Year Est. Return

Hansberger Global Investors's NVO Position: Q2 2014 in Review

Hansberger Global Investors held its Novo Nordisk (NVO) position steady in Q2 2014 at 57,500 shares worth $1.33M. The position accounts for 0.37% of the portfolio, ranked #19.

Hansberger Global Investors first reported a position in NVO in Q2 2013 and has held it in 5 quarters since. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

Hansberger Global Investors held 57,500 shares of Novo Nordisk worth $1.33M as of Q2 2014.
Hansberger Global Investors left its Novo Nordisk share count unchanged in Q2 2014.
Novo Nordisk made up 0.37% of Hansberger Global Investors's portfolio in Q2 2014, its #19 holding.
Hansberger Global Investors first reported a position in Novo Nordisk in Q2 2013 and has held it in 5 quarters since.
473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on Hansberger Global Investors's 13F filing for Q2 2014, filed 15 Jul 2014.